Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -21.62%31.41B | 44.98%47.81B | -23.66%103.51B | -50.44%28.17B | -94.99%2.29B | 75.62%40.07B | 219.61%32.98B | 33.54%135.59B | -34.72%56.84B | 756.38%45.61B |
Net income from continuing operations | 22.27%68.06B | -143.52%-109.04B | -114.92%-33.8B | -24.61%77.93B | -656.17%-417.93B | 23.75%55.67B | 8,010.65%250.54B | -18.92%226.59B | -59.62%103.37B | 386.69%75.15B |
Operating gains losses | 65.41%-8.71B | 167.20%215.9B | 93.07%314.11B | -204.24%-41.16B | 1,591.02%701.74B | -136.36%-25.19B | -2,683.92%-321.29B | 252.78%162.69B | 130.25%39.48B | -38.53%41.5B |
Depreciation and amortization | 14.40%2.46B | 11.60%1.98B | -7.20%6.55B | -0.61%2.45B | -92.75%176M | 30.69%2.15B | 241.54%1.78B | -5.33%7.06B | -60.70%2.47B | 376.27%2.43B |
Deferred tax | 204.36%20.92B | -141.72%-55.37B | 80.67%-46.34B | 117.30%17.69B | -200.89%-176.69B | 75.66%-20.05B | 3,566.16%132.72B | -1,180.57%-239.7B | -396.52%-102.24B | -160.53%-58.72B |
Other non cash items | -215.04%-41.09B | -123.81%-18.65B | -42.42%-102.14B | -12.32%-28.42B | -472.28%-101.11B | 281.19%35.72B | 7.80%-8.33B | 37.37%-71.72B | 72.12%-25.3B | -10.32%-17.67B |
Change In working capital | 40.04%-16.71B | 150.41%4.92B | -11,402.88%-47.85B | -313.33%-18.1B | 259.34%7.87B | -472.94%-27.87B | -1,176.30%-9.76B | -108.53%-416M | 94.90%8.48B | -431.17%-4.94B |
-Change in receivables | 44.47%-9.37B | 17.24%11.11B | 282.19%4.77B | -77.72%-6.98B | 433.79%19.15B | -238.54%-16.88B | 249.72%9.47B | -950.60%-2.62B | -5,136.00%-3.93B | 416.12%3.59B |
-Change in inventory | 624.66%4.2B | 163.80%215M | -576.79%-534M | -1,002.17%-415M | -123.46%-362M | 190.00%580M | -1,303.57%-337M | -82.95%112M | -94.68%46M | 18.18%-162M |
-Change in payables and accrued expense | 0.71%-11.32B | 65.97%-6.33B | -2,302.35%-51.47B | -183.52%-10.42B | -32.91%-11.04B | -45,504.00%-11.4B | -930.73%-18.62B | -55.45%2.34B | 197.24%12.47B | -984.35%-8.3B |
-Change in other working capital | -29.24%-221M | 76.41%-67M | -146.99%-615M | -161.47%-285M | 301.61%125M | -216.67%-171M | -1,083.33%-284M | 67.91%-249M | 82.81%-109M | -63.16%-62M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -21.62%31.41B | 44.98%47.81B | -23.66%103.51B | -50.44%28.17B | -94.99%2.29B | 75.62%40.07B | 219.61%32.98B | 33.54%135.59B | -34.72%56.84B | 756.38%45.61B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -93.63%5.8B | -196.69%-20.64B | -15.26%83.25B | -127.80%-3.71B | -134.21%-25.46B | 1,451.87%91.06B | 361.10%21.35B | 9.56%98.24B | -80.88%13.33B | 883.92%74.41B |
Net PPE purchase and sale | -23.30%-1.36B | -64.73%-1.25B | -154.64%-3.32B | 14.07%-873M | -107.50%-584M | -137.20%-1.1B | -220.76%-757M | 329.18%6.07B | 57.04%-1.02B | 31,252.00%7.79B |
Net intangibles purchase and sale | -1,587.10%-523M | -210.68%-960M | -37.29%-729M | -3.09%-267M | 17.01%-122M | 66.30%-31M | -836.36%-309M | -2.12%-531M | 65.60%-259M | 39.26%-147M |
Net business purchase and sale | 12.25%2.43B | -90.71%2.43B | 9,389.45%23.78B | 2,264.04%3.85B | -10,685.90%-8.41B | --2.16B | --26.18B | 82.42%-256M | 84.84%-178M | 65.18%-78M |
Net investment purchase and sale | -94.39%2.75B | 30.99%-10.82B | -77.16%6.46B | -419.92%-26.42B | -104.25%-518M | 712.15%49.07B | -977.17%-15.68B | 128.35%28.27B | 108.40%8.26B | 930.63%12.18B |
Net other investing changes | -81.69%238M | 237.89%222M | 23,642.86%1.66B | --411M | --112M | --1.3B | ---161M | -99.81%7M | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -93.63%5.8B | -196.69%-20.64B | -15.26%83.25B | -127.80%-3.71B | -134.21%-25.46B | 1,451.87%91.06B | 361.10%21.35B | 9.56%98.24B | -80.88%13.33B | 883.92%74.41B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 81.12%-32.61B | -15.53%-27.61B | 36.65%-190.94B | 81.57%-20.71B | 124.65%26.37B | -353.13%-172.69B | 45.56%-23.9B | -175.42%-301.4B | -36.97%-112.41B | -590.19%-106.98B |
Net issuance payments of debt | -10.61%52.1B | 71.04%-3.54B | 137.80%47.79B | 455.54%28.97B | 66.07%-27.25B | 490.17%58.29B | 66.45%-12.21B | -214.73%-126.43B | 119.60%5.21B | -814.47%-80.31B |
Net common stock issuance | 83.03%-1.26B | -191.34%-15.69B | -312.27%-26.71B | -263.59%-9.7B | -223.92%-4.21B | -747.89%-7.42B | -228.89%-5.38B | -148.81%-6.48B | -5.12%-2.67B | -1,840.30%-1.3B |
Cash dividends paid | 63.44%-70.07B | --0 | -27.07%-152.42B | 80.94%-18.99B | 940.03%58.21B | -1,328.54%-191.64B | --0 | -8,177.78%-119.95B | -7,786.06%-99.6B | -3,625.27%-6.93B |
Proceeds from stock option exercised by employees | 377.12%563M | 3,946.51%1.74B | 1,370.27%1.63B | 2,876.67%893M | 670.67%578M | 2,850.00%118M | 2,050.00%43M | 236.36%111M | 20.00%30M | 3,650.00%75M |
Net other financing activities | 1,566.67%44M | 21.13%86M | --96M | --24M | --4M | ---3M | --71M | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 81.12%-32.61B | -15.53%-27.61B | 36.65%-190.94B | 81.57%-20.71B | 124.65%26.37B | -353.13%-172.69B | 45.56%-23.9B | -175.42%-301.4B | -36.97%-112.41B | -590.19%-106.98B |
Net cash flow | ||||||||||
Beginning cash position | -54.69%30.24B | -12.81%31.73B | -68.29%32.45B | -63.90%20.98B | 97.51%34.92B | 726.59%66.75B | -2.00%36.39B | 303.45%102.33B | 400.31%58.13B | 24.93%17.68B |
Current changes in cash | 111.06%4.6B | -101.46%-443M | 93.81%-4.18B | 129.46%11.82B | -141.89%-4.87B | -327.95%-41.56B | 203.57%30.43B | -182.64%-67.58B | -153.69%-40.11B | 561.29%11.62B |
Effect of exchange rate changes | -93.88%894M | -153.33%-976M | 409.78%10.9B | -54.74%1.29B | -1,127.47%-6.84B | 3,196.82%14.62B | 473.67%1.83B | 232.88%2.14B | 366.17%2.85B | 2.96%-557M |
End cash Position | 4.99%36.66B | -54.69%30.24B | -12.81%28.3B | -12.81%28.3B | -63.90%20.98B | 97.51%34.92B | 726.59%66.75B | -68.29%32.45B | -68.29%32.45B | 400.31%58.13B |
Free cash flow | -24.17%29.52B | 42.92%45.6B | -24.72%99.45B | -50.97%27.03B | -96.47%1.58B | 75.14%38.94B | 217.52%31.91B | 34.35%132.11B | -34.52%55.13B | 748.84%44.7B |
Currency Unit | ARS | ARS | ARS | ARS | ARS | ARS | ARS | ARS | ARS | ARS |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |